Health & Community

Breaking News: WHO validates Sinovac COVID-19 Vaccine For Emergency Use

sinovac
899Views

WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac.

“The world desperately needs multiple COVID-19 vaccines to address the huge access inequity across the globe,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products. “We urge manufacturers to participate in the COVAX Facility, share their knowhow and data and contribute to bringing the pandemic under control.”

WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines. 

The EUL assesses the quality, safety and efficacy of COVID-19 vaccines, as well as risk management plans and programmatic suitability, such as cold chain requirements. The assessment is performed by the product evaluation group, composed by regulatory experts from around the world and a Technical Advisory Group (TAG), in charge of performing the risk-benefit assessment for an independent recommendation on whether a vaccine can be listed for emergency use and, if so, under which conditions.

In the case of the Sinovac-CoronaVac vaccine, the WHO assessment included on-site inspections of the production facility. 

The Sinovac-CoronaVac product is an inactivated vaccine. Its easy storage requirements make it very manageable and particularly suitable for low-resource settings.

WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has also completed its review of the vaccine. On the basis of available evidence, WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks. Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51% of those vaccinated and prevented severe COVID-19 and hospitalization in 100% of the studied population.

Few older adults (over 60 years) were enrolled in clinical trials, so efficacy could not be estimated in this age group. Nevertheless, WHO is not recommending an upper age limit for the vaccine because data collected during subsequent use in multiple countries and supportive immunogenicity data suggest the vaccine is likely to have a protective effect in older persons. There is no reason to believe that the vaccine has a different safety profile in older and younger populations. WHO recommends that countries using the vaccine in older age groups conduct safety and effectiveness monitoring to verify the expected impact and contribute to making the recommendation more robust for all countries.

WHO emergency use listing 

The emergency use listing (EUL) procedure assesses the suitability of novel health products during public health emergencies. The objective is to make medicines, vaccines and diagnostics available as rapidly as possible to address the emergency, while adhering to stringent criteria of safety, efficacy and quality. The assessment weighs the threat posed by the emergency as well as the benefit that would accrue from the use of the product against any potential risks.

The EUL pathway involves a rigorous assessment of late phase II and phase III clinical trial data as well as substantial additional data on safety, efficacy, quality and a risk management plan with a focus on low- and middle-income country needs. These data are reviewed by independent experts and WHO teams who consider the current body of evidence on the vaccine under consideration, the plans for monitoring its use, and plans for further studies.

As part of the EUL process, the company producing the vaccine must commit to continue to generate data to enable full licensure and WHO prequalification of the vaccine. The WHO prequalification process will assess additional clinical data generated from vaccine trials and deployment on a rolling basis to ensure the vaccine meets the necessary standards of quality, safety and efficacy for broader availability.

Listings

WHO has already  listed the Pfizer/BioNTechAstrazeneca-SK BioSerum Institute of IndiaAstra Zeneca EUJanssenModerna and Sinopharm vaccines for emergency use.

SAGE

SAGE is the principal advisory group to WHO for vaccines and immunization. It is charged with advising WHO on overall global policies and strategies, ranging from vaccines and immunization technology, research and development, to delivery of immunization and its linkages with other health interventions. SAGE is concerned not just with childhood vaccines and immunization, but all vaccine-preventable diseases.

SAGE assesses evidence on safety, efficacy, effectiveness, impact and programmatic suitability, considering both individual and public health impact.  SAGE Interim recommendations for EUL products provide guidance for national vaccination policy makers.  These recommendations are updated as additional evidence becomes available and as there are changes to the epidemiology of disease and the availability of additional vaccines and other disease control interventions.

SAGE has issued recommendations  on Pfizer (8 January 2021), Moderna (25 January 2021), AstraZeneca (21 April 2021), Janssen COVID (17 March 2021) and Sinopharm (7 May 2021) vaccines, as well as issued a framework for access and population prioritization roadmap. The SAGE interim recommendations on Sinovac-CoronaVac will be available online at 17:00 CEST today.

SAGE and EUL recommendations are complementary but independent processes. The EUL process is centred on determining if a manufactured product is quality-assured, safe and effective. SAGE is policy oriented, assessing safety, efficacy, public health impact, and programmatic feasibility. Policy recommendations for a vaccine are generally made only for those products that have been listed or authorized for use. 

In the context of COVID-19 and due the pressing need for vaccines, the Secretariat of SAGE and the EUL team have been working in parallel to allow WHO EUL and policy recommendations, based on the available evidence, to be issued in a synchronized manner.

Robert Tapfumaneyi

29 Comments

  • Excellent web site you have here.. It’s hard to find good quality writing like yours nowadays.
    I truly appreciate people like you! Take care!!

    My web site … Jayme

  • Hey there terrific website! Does running a blog like this take a great deal of work?
    I have virtually no expertise in programming however
    I was hoping to start my own blog soon. Anyways, should you have any
    suggestions or tips for new blog owners please share.
    I know this is off topic however I simply had to ask.
    Kudos!

    Here is my web-site: Florence

  • Everyone loves what you guys tend to be up too. This sort of clever work and
    exposure! Keep up the great works guys I’ve added you guys to my blogroll.

    Also visit my web blog; xe88 mod apk (Rodney)

  • I used to be recommended this blog by my cousin. I am now not sure
    whether this publish is written through him as
    nobody else recognise such exact approximately my difficulty.

    You are wonderful! Thank you!

    my website – 918kiss plus download ios

  • Aw, this was an incredibly nice post. Spending some time and actual effort to make a really good article…

    but what can I say… I put things off a whole lot and
    don’t seem to get anything done.

    Feel free to visit my site … Truvita CBD Review

  • I’m really enjoying the design and layout of your blog.

    It’s a very easy on the eyes which makes it much more pleasant for me to
    come here and visit more often. Did you hire out a developer to create your theme?
    Outstanding work!

    my homepage – ntc33 slot

  • hey there and thank you for your info – I’ve definitely picked up anything new from right here.
    I did however expertise some technical issues using this
    web site, as I experienced to reload the site lots of times previous to I could get it to load
    correctly. I had been wondering if your hosting is OK?
    Not that I’m complaining, but slow loading instances times will very frequently affect
    your placement in google and could damage your quality score if advertising and marketing with Adwords.
    Anyway I am adding this RSS to my e-mail and can look out for
    much more of your respective intriguing content.
    Make sure you update this again very soon.

    Feel free to visit my web site download slot game epicwin

  • Hello, Neat post. There is an issue along with your
    site in internet explorer, might check this? IE still is the market leader and a large element of folks will pass over your wonderful writing due to this problem.

    Also visit my page :: Nitro Strive Nitric Oxide

  • That is a very good tip especially to those new to the blogosphere.
    Simple but very precise info… Many thanks for sharing this one.
    A must read article!

    Feel free to visit my page: slot mega888

  • Wow that was unusual. I just wrote an really long comment but after I clicked submit my comment didn’t appear.
    Grrrr… well I’m not writing all that over again. Regardless,
    just wanted to say excellent blog!

    Also visit my web site kiosk sky1388

  • I used to be recommended this web site by way
    of my cousin. I’m now not certain whether this
    publish is written by means of him as nobody else recognise such detailed approximately my trouble.
    You are wonderful! Thanks!

    Feel free to surf to my web page … m joker123apk

  • Superb blog! Do you have any tips and hints for aspiring writers?
    I’m hoping to start my own blog soon but I’m a little lost on everything.
    Would you propose starting with a free platform like WordPress or go
    for a paid option? There are so many choices out there that I’m totally overwhelmed ..
    Any tips? Thanks!

    Also visit my homepage; love138 android download

  • Aw, this was a really nice post. Finding the time and actual effort to produce a good article…
    but what can I say… I hesitate a whole lot and
    don’t seem to get nearly anything done.

    My web-site :: Brandy

  • I have been surfing online more than 4 hours today, yet I never found any interesting article like yours.
    It’s pretty worth enough for me. In my opinion, if all web
    owners and bloggers made good content as you did, the net will be much more useful
    than ever before.

    Take a look at my homepage – download game lpe88

  • Hi, i feel that i noticed you visited my web site thus i came to go back the prefer?.I
    am trying to to find issues to improve my site!I guess its good
    enough to make use of a few of your concepts!!

    My blog post; wukong333 test id

  • I’m extremely impressed together with your writing abilities as neatly as with the format for your
    blog. Is this a paid subject or did you modify it your self?
    Either way stay up the nice quality writing, it is uncommon to see a
    nice weblog like this one today..

    My website :: 918kaya ios download

  • I was reading through some of your posts on this internet site
    and I conceive this web site is really informative!
    Keep on putting up.

    Look into my website: Slimingo

Leave a Reply